Earnings Feed
Start Free
Esperion Therapeutics, Inc.·4

Feb 9, 5:47 PM ET

NEWTON ROGER S 4

4 · Esperion Therapeutics, Inc. · Filed Feb 9, 2018

Insider Transaction Report

Form 4
Period: 2018-02-07
Esperion Therapeutics, Inc.ESPR
NEWTON ROGER S
DirectorExecutive Chairman, CSO
Transactions
  • Gift

    Common Stock

    2017-12-12−12,000→ 617,683 total
  • Exercise/Conversion

    Common Stock

    2018-02-07$6.99/sh+34,651$242,210→ 652,334 total
  • Tax Payment

    Common Stock

    2018-02-07$6.99/sh−3,608$25,220→ 648,726 total
  • Exercise/Conversion

    Warrant to Purchase Common Stock

    2018-02-07−34,651→ 0 total
    Exercise: $6.99Exp: 2018-02-12→ Common Stock (34,651 underlying)
Footnotes (1)
  • [F1]Fully exercisable as of the date hereof.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -